Skip to content

Clinical trials

Terminated Phase 3 Hemophilia A trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 3 Status: Terminated Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20112
20122
20161
20181
20213
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Baxalta now part of Shire3
Margaret Ragni2
ApcinteX Ltd1
Bio Products Laboratory1
CSL Behring1
Laboratoire français de Fractionnement et de Biotechnologies1
Novo Nordisk A/S1
Tremeau Pharmceuticals, Inc.1
University of Pittsburgh1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A13
Arthralgia1
Blood Coagulation Disorders1
Coagulation Protein Disorders1
Hematologic Diseases1
Hemophilia B1
Hemorrhagic Disorders1
Hemostatic Disorders1
Pain1
von Willebrand Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.